CELSIUS THERAPEUTICS
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients. The company is a group of scientists, technologists, computational biologists, clinicians, and drug hunters who use single-cell genomics and machine learning analysis to find new drugs. Celsius Therapeutics was founded in 2018 and is headquartered in Cambridge, Massachusetts.
CELSIUS THERAPEUTICS
Industry:
Biotechnology Emergency Medicine Genetics Health Care
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.celsiustx.com
Total Employee:
11+
Status:
Active
Contact:
857-776-7400
Total Funding:
148 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag
Similar Organizations
Adaptilens
Adaptilens develop an accommodating intraocular lens.
Alavida
Alavida offers the Scientific Solution for Alcohol Addiction.
ATTWILL Vascular Technologies
Medical Device, Biotech, Life Science
Biogazelle
Biogazelle is a specialist in genomic testing solutions.
Cambridge Nutraceuticals
Cambridge Nutraceuticals develops and markets supplements scientifically proven to deliver more of the good.
Cardiol Therapeutics
Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.
Cerecor
Cerecor discovers, develops and commercializes neuroscience drugs.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
FRESH WIND GROUP HOLDING LIMITED
Cell Therapy
GelSana Therapeutics
GelSana Therapeutics develops new products to heal wounds faster.
Made of Genes
MOG is your personal genomics company.
GEXVal
GEXVal is to help patients and families fighting against orphan and intractable diseases
Glycemicon
Glycemicon`s efforts are focused on the discovery, development and commercialization of innovative.
Aven
Inventing new ways to save people money
HumanCode
HumanCode develops next-generation personal genomics applications.
Incisive Genetics
Incisive Genetics is developing a delivery platform for genetic therapies.
Inner Cosmos
Inner Cosmos is the neurotechnology company that creates Brain Computer Interface (BCI) - NeuroMedicine.
Inno-Gene
The project of reading human genome
Insitome
Insitome uncovers your personal genomic story.
Invictus Oncology
Invictus Oncology develops therapeutics for cancer treatment.
Kalocyte
Kalocyte provides red blood cell substitutes used for trauma care related services.
Kefiplant
Kefiplant’s mission is to be a world leader in the production of fermented herbs.
Live Better With
Make life a little bit better with 100s of recommended products for people living with cancer.
Manicube
Manicube's mission is to make the lives of working women easier by revolutionizing the personal care services industries.
MEDCARE
Medcare leads the sustainable society and medical systems by its cutting-edge, optimized mix of therapy and prevention measures.
Mutabilis
Mutabilis is discovery of new therapeutic targets for the development of anti-infectives.
Neopenda
Neopenda innovates needs-based medical technologies for high-growth emerging markets.
Nura Bio
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines.
Phyla
Phyla is developing alternative therapies for antibiotics.
Phosphorus
Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine.
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Scandinavian Biolabs
Scandinavian Biolabs is founded of natural functionality, and real impact. Our vision is to end suffering arising from hair loss.
Summit Street Medical
Summit Street Medical provides food allergy care and coaching services.
Volta Labs
Volta Labs develops scalable automation for genetic engineering.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_member
2022-03-24
Current Employees Featured
Aviv Regev Co-Founder @ Celsius Therapeutics
Co-Founder
Michael Boretti CBO @ Celsius Therapeutics
CBO
Nicolas Stransky VP, Head of Data Science and Computational Biology @ Celsius Therapeutics
VP, Head of Data Science and Computational Biology
2020-12-01
Tariq Kassum CEO @ Celsius Therapeutics
CEO
2019-06-01
Sarah Grant Chief Medical Officer @ Celsius Therapeutics
Chief Medical Officer
2022-01-01
Andrea Armstrong Chief Administrative Officer @ Celsius Therapeutics
Chief Administrative Officer
Jeanne Magram CSO @ Celsius Therapeutics
CSO
Founder
Investors List
Catalio Capital Management
Catalio Capital Management investment in Series B - Celsius Therapeutics
Amgen Ventures
Amgen Ventures investment in Series B - Celsius Therapeutics
Amplitude Venture Capital
Amplitude Venture Capital investment in Series B - Celsius Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Celsius Therapeutics
Cowin Venture
Cowin Venture investment in Series B - Celsius Therapeutics
GV
GV investment in Series B - Celsius Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Celsius Therapeutics
Section 32
Section 32 investment in Series B - Celsius Therapeutics
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series B - Celsius Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series B - Celsius Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-25 | Celsius Therapeutics Appoints Sarah Grant, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.celsiustx.com Semrush global rank: 1.59 M Semrush visits lastest month: 16.12 K
- Host name: 159.180.132.176
- IP address: 159.180.132.176
- Location: North Chicago United States
- Latitude: 42.325
- Longitude: -87.8561
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60064
More informations about "Celsius Therapeutics"
Celsius Therapeutics is now a part of AbbVie | AbbVie
As one company, our ~50,000 employees around the world focus on discovering and delivering transformational medicines and products.See details»
Celsius Therapeutics - LinkedIn
Celsius Therapeutics is a community of scientists, technologists, clinicians and drug hunters leveraging single-cell RNA sequencing and genomic analysis to develop life-changing medicines.See details»
Celsius Therapeutics - Crunchbase Company Profile & Funding
Organization. Celsius Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@celsiustx.com; …See details»
AbbVie Acquires Celsius Therapeutics - Jun 27, 2024
Jun 27, 2024 Celsius' CEL383 is a potential first-in-class anti-Triggering Receptor Expressed on Myeloid Cells 1 (TREM1) antibody for the treatment of inflammatory bowel disease (IBD); …See details»
AbbVie Acquires Celsius Therapeutics - Yahoo Finance
Jun 27, 2024 AbbVie (NYSE: ABBV) announced today the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology company pioneering new therapies for patients …See details»
Celsius Therapeutics: Contact Details and Business Profile
Celsius Therapeutics is a community of scientists, technologists, clinicians and drug hunters leveraging single-cell RNA sequencing and genomic analysis to develop life-changing medicines.See details»
Celsius Therapeutics, Inc. Company Profile | Cambridge, MA ...
Celsius Therapeutics, Inc. Company Profile | Cambridge, MA | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Celsius Therapeutics - Craft
See insights on Celsius Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Working At Celsius Therapeutics: Company Overview and Culture
Celsiustx.com. Organization Type. Private. CEO. Tariq Kassum. Social Media. Celsius Therapeutics develop life-changing medicines and discover critical biomarkers for patient care …See details»
Celsius Therapeutics (USA) Funding: $148M - Medical Startups
Apr 2, 2025 Website: https://www.celsiustx.com Celsius Therapeutics develop life-changing medicines and discover critical biomarkers for patient care by better understanding the cellular …See details»
AbbVie Acquires Celsius Therapeutics - PR Newswire
Jun 27, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology company...See details»
Celsius Therapeutics Highlights Recent Accomplishments and Key ...
Mar 24, 2022 For more information, please visit www.celsiustx.com, or follow us on LinkedIn or Twitter. Contacts. Media Contact Katie Engleman, 1AB katie@1abmedia.com. Social Media …See details»
Celsius Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Celsius Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 20 news, Disease Domain:Neoplasms, Technology Platform:Monoclonal …See details»
Celsius Therapeutics - Work in biotech
Celsius Therapeutics is leveraging the power of Single Cell Genomics and Machine Learning to develop precision medicines for cancer and autoimmune diseases. Dysfunctional cells can …See details»
Celsius Therapeutics Names Scientific Advisers | Business Wire
Sep 22, 2022 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Celsius Therapeutics, a biotechnology company pioneering new precision medicines for patients with cancer and autoimmune …See details»
AbbVie Acquires Celsius Therapeutics - Nasdaq
Jun 27, 2024 --AbbVie announced today the acquisition of Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease. …See details»
Celsius Therapeutics - Overview, News & Similar companies
Celsius Therapeutics contact info: Phone number: (857) 776-7400 Website: www.celsiustx.com What does Celsius Therapeutics do? Celsius Therapeutics is charting a new course of target …See details»
AbbVie Acquires Celsius Therapeutics - BioSpace
Jun 27, 2024 Celsius' CEL383 is a potential first-in-class anti-Triggering Receptor Expressed on Myeloid Cells 1 (TREM1) antibody for the treatment of inflammatory bowel disease (IBD); …See details»
Celsius Therapeutics Initiates Phase 1 Trial for Anti-TREM1 Antibody
For more information, please visit https://celsiustx.com, or follow us on LinkedIn or Twitter. About Fast Track Initiative: Established in 2004, Fast Track Initiative, Inc. (FTI) is a life science …See details»
Nextsource | Company Profile | Celsius Therapeutics
Explore the company profile of Celsius Therapeutics (celsiustx.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»